Alnylam Pharmaceuticals (ALNY) Exchange Rate Effect (2009 - 2026)
Alnylam Pharmaceuticals posted quarterly Exchange Rate Effect of -$7.1 million for Q1 2026, down 150.25% year-on-year from $14.1 million in Q1 2025, and down 23.91% on a QoQ basis from -$5.7 million in Q4 2025.
Alnylam Pharmaceuticals (ALNY) has 9 years of Exchange Rate Effect data on file, last reported at -$7.1 million in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 150.25% year-over-year to -$7.1 million; the trailing twelve-month figure through Mar 2026 stood at $13.8 million (up 57.69% YoY), and the FY2025 full-year result was $34.9 million, up 329.25% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$7.1 million, down from -$5.7 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $27.5 million in Q2 2025 and bottomed at -$17.3 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$927000.0 (2025), against an average of $682000.0.
- The widest annual swing landed in 2024, when Exchange Rate Effect sank 2300.0%; it then soared 981.6% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at $1.6 million in 2022, then soared by 573.07% to $10.9 million in 2023, then sank by 258.49% to -$17.3 million in 2024, then surged by 66.99% to -$5.7 million in 2025, then dropped by 23.91% to -$7.1 million in 2026.
- The last three Exchange Rate Effect figures came in at -$7.1 million (Q1 2026), -$5.7 million (Q4 2025), and -$927000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.06 Mn |
| Mar 31, 2026 | -7.06 Mn |
| Dec 31, 2025 | -5.70 Mn |
| Dec 31, 2025 | -5.70 Mn |
| Sep 30, 2025 | -927,000.00 |
| Sep 30, 2025 | -927,000.00 |
| Jun 30, 2025 | 27.51 Mn |
| Jun 30, 2025 | 27.51 Mn |
| Mar 31, 2025 | 14.06 Mn |
| Mar 31, 2025 | 14.06 Mn |
| Dec 31, 2024 | -17.27 Mn |
| Dec 31, 2024 | -17.27 Mn |
| Sep 30, 2024 | 15.09 Mn |
| Sep 30, 2024 | 15.09 Mn |
| Jun 30, 2024 | -3.12 Mn |
| Jun 30, 2024 | -3.12 Mn |
| Mar 31, 2024 | -9.94 Mn |
| Mar 31, 2024 | -9.94 Mn |
| Dec 31, 2023 | 10.90 Mn |
| Dec 31, 2023 | 10.90 Mn |
| Sep 30, 2023 | -6.55 Mn |
| Sep 30, 2023 | -6.55 Mn |
| Jun 30, 2023 | -130,000.00 |
| Jun 30, 2023 | -130,000.00 |
| Mar 31, 2023 | 2.18 Mn |
| Mar 31, 2023 | 2.18 Mn |
| Dec 31, 2022 | 1.62 Mn |
| Dec 31, 2022 | 1.62 Mn |
| Sep 30, 2022 | 2.02 Mn |
| Sep 30, 2022 | 2.02 Mn |
| Jun 30, 2022 | -8.84 Mn |
| Jun 30, 2022 | -8.84 Mn |
| Mar 31, 2022 | -2.24 Mn |
| Mar 31, 2022 | -2.24 Mn |
| Dec 31, 2021 | -3.05 Mn |
| Dec 31, 2021 | -3.05 Mn |
| Sep 30, 2021 | -3.14 Mn |
| Sep 30, 2021 | -3.14 Mn |
| Jun 30, 2021 | 1.08 Mn |
| Jun 30, 2021 | 1.08 Mn |
| Mar 31, 2021 | -3.91 Mn |
| Mar 31, 2021 | -3.91 Mn |
| Dec 31, 2020 | 2.97 Mn |
| Dec 31, 2020 | 2.97 Mn |
| Sep 30, 2020 | 2.14 Mn |
| Sep 30, 2020 | 2.14 Mn |
| Jun 30, 2020 | 435,000.00 |
| Jun 30, 2020 | 435,000.00 |
| Mar 31, 2020 | -631,000.00 |
| Mar 31, 2020 | -631,000.00 |
| Dec 31, 2019 | 366,000.00 |
| Dec 31, 2019 | 366,000.00 |
| Sep 30, 2019 | -446,000.00 |
| Sep 30, 2019 | -446,000.00 |
| Jun 30, 2019 | -3,000.00 |
| Jun 30, 2019 | -3,000.00 |
| Dec 31, 2009 | -4,000.00 |
| Dec 31, 2009 | -4,000.00 |
| Sep 30, 2009 | -4,000.00 |
| Sep 30, 2009 | -4,000.00 |